Endovascular and interventional procedures in obese patients: A review of procedural technique modifications and radiation management

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 1, 2006, Pages 27-33

  Bryk, Scott G ^a   Censullo, Michael L ^a   Wagner, Louis K ^a   Rossman, Lucho L ^a   Cohen, Alan M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED CONTRAST MEDIUM; METFORMIN; ORAL ANTIDIABETIC AGENT;

AIRWAY OBSTRUCTION; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY DISEASE; COMORBIDITY; DRUG HYPERSENSITIVITY; HUMAN; IMAGE QUALITY; LACTIC ACIDOSIS; LIVER BIOPSY; LIVER DISEASE; LUNG BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR ACCESS; FLUOROSCOPY; INTERVENTIONAL RADIOLOGY; METHODOLOGY; RADIOGRAPHY;

FLUOROSCOPY; HUMANS; OBESITY; RADIATION DOSAGE; RADIOGRAPHY, INTERVENTIONAL;

EID: 33744772191     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000186953.44651.19     Document Type: Review

References (85)

1. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289:76-79.
2. Athanasoulis CA. Vascular radiology: looking into the past to learn about the future. Radiology 2001; 218:317-322.
3. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999; 282:1523-1529.
4. Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med 2000; 160:898-904.
5. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004; 23:6365-6378.
6. Tominaga S, Kuroishi T. Epidemiology and prevention of breast cancer in the 21st Century. Breast Cancer 1999; 6:283-288.
7. Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 2004; 42:1-9.
8. James WP. What are the health risks? The medical consequences of obesity and its health risks. Exp Clin Endocrinol Diabetes 1998;106(suppl 2):1-6.
9. Melanson KJ, McInnis KJ, Rippe JM, et al. Obesity and cardiovascular disease risk: research update. Cardiol Rev 2001; 9:202-207.
10. Dunnick NR, Sandler CM, Newhouse JH. Textbook of Uroradiology, Third edition. Philadelphia: Lippincott Williams & Wilkins, 2001.
11. Thomsen HS, Morcos SK. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in noninsulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee. Eur Radiol 1999; 9:738-740.
12. Rasuli P, Hammond DI. Metformin and contrast media: where is the conflict? Can Assoc Radiol J 1998; 49:161-166.
13. American College of Radiology. Iodinated contrast media, third edition: report of the Committee on Drugs and Contrast Media, 1997-1998. Reston, VA: American College of Radiology, 1998;19-25.
14. Asif A, Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 2004; 44:12-24.
15. Asif A, Preston RA, Roth D. Radiocontrast-induced nephropathy. Am J Ther 2003; 10:137-47. Review.
16. Koenig TR, Mettler FA, Wagner LK. Skin injuries from fluoroscopically guided procedures: part 2, review of 73 cases and recommendations for minimizing dose delivered to patient. AJR Am J Roentgenol 2001; 177:13-20.
17. Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys 1999; 43:475-479.
18. Kincaid-Smith P. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labeled hypertensive nephrosclerosis'. J Hypertens 2004; 22:1051-1055.
19. Bojestig M, Arnqvist HJ, Hermansson G, et al. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330:15-18.
20. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 143-149.
21. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low osmolality iodinated contrast media. Radiology 1993; 188:171-178.
22. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 1999; 72:701-703.
23. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxicity in high-risk patients. Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348:491-499.
24. Erdogan A, Davidson CJ. Recent clinical trials of iodixanol. Rev Cardiovasc Med 2003; 4 (suppl 5):S43-S50.
25. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162:329-336.
26. Morcos SK. Prevention of contrast media nephrotoxicity-the story so far. Clin Radiol 2004; 59:381-389.
27. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291:2328-2334.
28. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8:521-533.
29. Haynes P, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease in individuals with severe obesity. Clin Liver Dis 2004; 8:535-547.
30. Denk H, Stumptner C, Fuchsbichler A, et al. Alcoholic and nonalcoholic steatohepatitis: histopathologic and pathogenetic considerations. Pathologe 2001; 388-398. German.
31. Spaulding L, Trainer T, Janiec D. Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass. Obes Surg 2003; 13:347-349.
32. Denninger MH. Liver diseases and hemostasis. Pathol Biol (Paris) 1999; 47:1006-1015. French.
33. Montravers P, Dureuil B, Desmonts JM. Effects of i.v. midazolam on upper airway resistance. Br J Anaesth 1992; 68:27-31.
34. Eastwood PR, Szollosi I, Platt PR, et al. Comparison of upper airway collapse during general anesthesia and sleep. Lancet 2002; 359:1207-1209.
35. Agro F, Salvinelli F, Casale M, et al. Difficulty in airway management during sedation of patients affected by obstructive sleep apnea. Can J Anaesth 2004; 51:279.
36. Wagner LK, Archer BR. Minimizing the risks from fluroscopic xrays; bioeffects, instrumentation and examination, 4th ed. The Woodlands, TX: Partners in Radiation Management, 2004.
37. Cardinal HN, Holdsworth DW, Drangova M, Hobbs BB, Fenster A. Experimental andtheoretical x-ray imaging performance comparison of iodine and lanthanide contrast agents. Med Phys 1993; 15-31.
38. McParland BJ, Boyd MM. X-ray image intensifier performance and patient doses for combinations of supplemental beam filters and vascular contrast agents. Phys Med Biol 2001; 227-244.
39. Nyman U, Elmstahl B, Leander P, et al. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 2002; 223:311-318.
40. Nyman U, Elmstahl B, Leander P, et al. Commentary on the viewpoint of Spinosa et al. Radiology 2002; 223:326-327.
41. Spinosa DJ, Kaufmann JA, Hartwell GD. Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology 2002; 223:319-325.
42. Wagner LK, Archer BR, Cohen AM. Management of patient skin dose in fluoroscopically guided interventional procedures. J Vasc Interv Radiol 2000; 11:25-33.
43. Miller DL, Balter S, Wagner LK, et al. Quality Improvement Guidelines for recording patient radiation dose in the medical Record. J Vasc Interv Radiol 2004; 15:423-429.
44. Balter S, Shope TB, Jr, Fletcher, DW, et al. Techniques to estimate radiation dose to skin during fluoroscopically guided procedures. In: Balter S, Chan RC, Shope TB, Jr, eds. Intravascular brachytherapy: fluoroscopically guided interventions. Madison, WI: Medical Physics Publishing, 2002;731-764.
45. Hildick-Smith DJ, Walsh JT, Lowe MD, et al. Transradial coronary angiography in patients with contraindications to the femoral approach: an analysis of 500 cases. Catheter Cardiovasc Interv 2004; 61:60-66.
46. Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn 1989; 16:3-7.
47. Matsumoto Y, Hokama M, Nagashima H, et al. Transradial approach for selective cerebral angiography: technical note. Neurol Res 2000; 22:605-608.
48. Matsumoto Y, Hongo K, Toriyama T, et al. Transradial approach for diagnostic selective cerebral angiography: results of a consecutive series of 166 cases. Am J Neuroradiol 2001; 22:704-708.
49. Horlocker TT, Bishop AT. Compartment syndrome of the forearm and hand after brachial artery cannulation. Anesth Analg 1995; 81:1092-1094.
50. Clark VL, Kruse JA. Arterial catheterization. Crit Care Clin 1992; 8:687-697.
51. Ngan MF. Sonographically guided arterial blood sampling using a hand-held Doppler device. J Clin Ultrasound 2002; 30:158-60.
52. Battikh K, Rihani R, Lemahieu JM, et al. Intra-arterial thrombolysis of a basilar vascular accident during coronary angiography. Arch Mal Coeur Vaiss 2001; 94:1025-1027. French.
53. Rodde A, Bazin C, Blum A, et al. Selective arteriography of the supra-aortic trunks by right humeral approach with a 4F catheter. J Radiol 1993; 74:657-660. French.
54. Mitchel RS, Dake MD, Semba CP, et al. Endovascular stent-graft repair of thoracic aortic aneurysms. J Thorac Cardiovasc Surg 1996; 111:1054-1062.
55. Kuduvalli M, Grayson AD, Oo AY, et al. Risk of morbidity and inhospital mortality in obese patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 2002; 22:787-793.
56. Klasen J, Junger A, Hartmann B, et al. Increased body mass index and perioperative risk in patients undergoing non-cardiac surgery. Obes Surg 2004; 14:275-281.
57. Wiskirchen J, Kraemer K, König C, et al. Radiopacity of current endovascular stents: evaluation in a multiple reader phantom study. J Vasc Interv Radiol 2004; 15:843-852.
58. Wiskirchen J, Venugopalan R, Holton AD, et al. Radiopaque markers in endovascular stents-benefit and potential hazards Rofo 2003; 175:484-488.
59. Wong P, Harding S, Walters D, et al. Vascular complications after hemostatic puncture closure device (Angio-Seal) are not higher in overweight patients. J Invas Cardiol 2001; 13:623-625.
60. Teh LG, Sieunarine K, van Schie G, et al. Use of the percutaneous vascular surgery device for closure of femoral access sites during endovascular aneurysm repair: lessons from our experience. Eur J Vasc Endovasc Surg 2001; 22:418-423.
61. Cox N, Resnic FS, Popma JJ, et al. Comparison of the risk of vascular complications with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol 2004; 94:1174-1177.
62. Kim A, Fusman B, Jolly N, et al. Percutaneous suture closure for brachial artery puncture. J Interv Cardiol 2002; 15:277-280.
63. Mey U, Glasmacher A, Hahn C, et al. Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients. Support Care Cancer 2003; 148-155.
64. Fry WR, Clagett GC, O'Rourke PT. Ultrasound-guided central venous access. Arch Surg 1999; 134:738-740.
65. Nevarre DR, Domingo OH. Supraclavicular approach to subclavian catheterization: review of the literature and results of 178 attempts by the same operator. J Trauma 1997; 42:305-309.
66. Giesy J. External jugular vein access to central venous system. JAMA 972; 219:1216-1217.
67. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics 2002; 110:e51.
68. Craft PS, May J, Dorigo A, et al. Hickman catheters: left-sided insertion, male gender, and obesity are associated with an increased risk of complications. Aust N Z J Med 1996; 26:33-39.
69. Heit JA. Venous thromboembolism epidemiology: implications for prevention and management. Semin Thromb Hemost 2002; 28(suppl 2):3-13.
70. Charboneau JW, Reading CC, Welch TJ. AJR Am J Roentgenol 1990; 155:198.
71. Garg M, Sandhu M, Sood B, et al. Tissue harmonic imaging in the evaluation of acute pancreatitis. Australas Radiol 2004; 48:117-122.
72. Lee SM, King J, Spargo BH. Efficacy of percutaneous renal biopsy in obese patients under computerized tomographic guidance. Clin Nephrol 1991; 35:123-129.
73. Fine DM, Arepally A, Hofmann LV, et al. Diagnostic utility and safety of transjugular kidney biopsy in the obese patient. Nephrol Dial Transplant 2004; 19:1798-1802.
74. Bilbao JI, Idoate F, Joly MA, et al. Renal biopsy with forceps through the femoral vein. J Vasc Interv Radiol 1995; 641-645.
75. Babb RR, Jackman RJ. Needle biopsy of the liver: a critique of four currently available methods. West J Med 1989; 150:39-42.
76. Ahmad M, Riley TR III. Can one predict when ultrasound will be useful with percutaneous liver biopsy? Am J Gastroenterol 2001;96:547-549.
77. Colapinto RF. Transjugular biopsy of the liver. Clin Gastroenterol 1985; 14:451-67.
78. Brenard R, Horsmans Y, Rahier J, et al. Transjugular liver biopsy: an experience based on 500 procedures. Acta Gastroenterol Belg 1997; 60:138-141.
79. Bruzzi JF, O'Connell MJ, Thakore H, et al. Transjugular liver biopsy: assessment of safety and efficacy of the quick-core biopsy needle. Abdom Imaging 2002; 27:711-715.
80. Munk PL, Morris DC, Connell DG, et al. Transfemoral venous liver biopsy: common problems and complications. Australas Radiol 1999; 43:160-164.
81. Teare JP, Watkinson AF, Erb SR, et al. Transfemoral liver biopsy by forceps: a review of 104 consecutive procedures. Cardiovasc Intervent Radiol 1994; 17:252-257.
82. McAfee JH, Keeffe EB, Lee RG, et al. Transjugular liver biopsy. Hepatology 1992; 15:726-732.
83. Maciel AC, Marchiori E, de Barros SG, et al. Transjugular liver biopsy: histological diagnosis success comparing the Trucut to the modified aspiration Ross needle. Arq Gastroenterol 2003; 40:80-84.
84. Khosa F, McNulty JG, Hickey N, et al. Transvenous liver biopsy via the femoral vein. Clin Radiol 2003; 58:487-491.
85. Bonn J, Liu JB, Eschelman DJ, et al. Intravascular ultrasound as an alternative to positive-contrast vena cavography prior to filter placement. J Vasc Interv Radiol 1999; 10:843-849.